Eisai Co Ltd is a specialty and generic drug manufacturing company... Show more
ESAIY moved below its 50-day moving average on March 26, 2025 date and that indicates a change from an upward trend to a downward trend. In of 10 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .
The 10-day moving average for ESAIY crossed bearishly below the 50-day moving average on March 26, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 3 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ESAIY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for ESAIY entered a downward trend on April 17, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ESAIY's RSI Indicator exited the oversold zone, of 20 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 27 cases where ESAIY's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on April 16, 2025. You may want to consider a long position or call options on ESAIY as a result. In of 35 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for ESAIY just turned positive on April 16, 2025. Looking at past instances where ESAIY's MACD turned positive, the stock continued to rise in of 20 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ESAIY advanced for three days, in of 122 cases, the price rose further within the following month. The odds of a continued upward trend are .
ESAIY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.192) is normal, around the industry mean (60.843). P/E Ratio (46.083) is within average values for comparable stocks, (89.540). ESAIY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.913). Dividend Yield (0.045) settles around the average of (0.120) among similar stocks. P/S Ratio (3.429) is also within normal values, averaging (20.019).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ESAIY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ESAIY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
Industry PharmaceuticalsOther
A.I.dvisor tells us that ESAIY and ESALF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESAIY and ESALF's prices will move in lockstep.
Ticker / NAME | Correlation To ESAIY | 1D Price Change % | ||
---|---|---|---|---|
ESAIY | 100% | +0.74% | ||
ESALF - ESAIY | 30% Poorly correlated | N/A | ||
GEDSF - ESAIY | 28% Poorly correlated | N/A | ||
SDZNY - ESAIY | 8% Poorly correlated | +0.35% | ||
PLNH - ESAIY | 7% Poorly correlated | -3.74% | ||
CNADF - ESAIY | 5% Poorly correlated | N/A | ||
More |